|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.900 EUR | +1.04% |
|
-1.02% | +13.37% |
| 05-05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 188M 215M 174M 162M 305M 20.31B 312M 2.09B 807M 10.02B 807M 789M 34.79B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 188M 215M 174M 162M 305M 20.31B 312M 2.09B 807M 10.02B 807M 789M 34.79B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.23x |
| Free-Float |
12.27% | Yield 2026 * |
1.01% | Yield 2027 * | 1.01% |
| 1 day | +1.04% | ||
| 1 week | -1.02% | ||
| Current month | +7.14% | ||
| 1 month | +7.14% | ||
| 3 months | +15.38% | ||
| 6 months | +14.04% | ||
| Current year | +13.37% |
| 1 week | 3.84 |  | 3.9 |
| 1 month | 3.64 | | 4.18 |
| Current year | 3.26 | | 4.18 |
| 1 year | 2.84 | | 4.18 |
| 3 years | 2.2 | | 4.18 |
| 5 years | 2.2 | | 4.2 |
| 10 years | 2.2 | | 6.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 30/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 31/12/2002 |
Michael Bock
BRD | Director/Board Member | 63 | 24/05/2005 |
| Director/Board Member | 63 | 19/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.04% | -1.02% | - | - | 215M | |
| -1.64% | -4.55% | +25.00% | +43.10% | 18.46B | |
| +0.73% | +1.95% | +18.42% | +68.82% | 13.1B | |
| +7.50% | +3.99% | -30.65% | -54.62% | 10.93B | |
| -0.42% | +2.93% | -17.43% | +50.93% | 10.05B | |
| -2.98% | +2.95% | +3.16% | +68.22% | 9.45B | |
| +2.65% | +6.01% | -4.90% | -30.09% | 9B | |
| -0.46% | -1.30% | +21.22% | +211.56% | 7.64B | |
| +2.37% | +11.72% | +22.15% | -23.02% | 6.84B | |
| -2.22% | -3.93% | -16.98% | - | 6.81B | |
| Average | +0.66% | +2.50% | +2.22% | +41.86% | 10.25B | |
| Weighted average by Cap. | +0.55% | +1.89% | +4.08% | +40.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 899M 727M 679M 1.28B 85.03B 1.31B 8.75B 3.38B 41.95B 3.38B 3.3B 146B | 803M 917M 742M 692M 1.3B 86.73B 1.33B 8.92B 3.44B 42.79B 3.45B 3.37B 149B |
| Net income | 36.66M 41.87M 33.85M 31.61M 59.5M 3.96B 60.85M 407M 157M 1.95B 157M 154M 6.78B | 38.2M 43.62M 35.26M 32.93M 61.98M 4.12B 63.4M 424M 164M 2.03B 164M 160M 7.06B |
| Net Debt | - | - |
Employees
7,416
Calendar
07-30 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/06/26 | €3.900 | +1.04% | 90 |
| 26/06/26 | €3.860 | +0.52% | 0 |
| 25/06/26 | €3.840 | -0.52% | 0 |
| 24/06/26 | €3.860 | 0.00% | 0 |
| 23/06/26 | €3.860 | -2.03% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.960EUR
Average target price
7.300EUR
Spread / Average Target
+84.34%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
